Grayzel David S.'s Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Apr 11, 2024
- Accession no.
- 0001415889-24-010709
- Filed
- Apr 11, 2024
- Trade date
- Apr 9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $334.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grayzel David S.CIK 0001732786 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | SSaleDisposed | −11,882 | $28.15 | −$334,478.3 | 14,502 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.